Pfizer Names Dr. Chris Boshoff Chief Scientific Officer

Pfizer·May 6

✦ NabkaNews BriefAuto-summarized from multiple outlets · verify with the source

Pfizer has named Dr. Chris Boshoff as its new chief scientific officer. Boshoff, who previously headed the company's oncology division, will also serve as president of research and development. The move appears to be part of a strategic shift, with some outlets suggesting it reflects a continued commitment to the company's current approach.

Full coverage

Pfizer, under pressure to change, names oncology head as new R&D chief

BioPharma Dive·Nov 20

Pfizer names oncology head Chris Boshoff as R&D chief

Reuters·Nov 20

Pfizer Appoints New Chief Scientific Officer and President, Research and Development

Applied Clinical Trials Online·Nov 20

Pfizer promoted oncology chief Chris Boshoff to serve as CSO, R&D president

Medical Marketing and Media·Nov 20

Pfizer Names New Chief Scientific Officer and President of R&D

Contract Pharma·Nov 20

Doubling down on its strategy, Pfizer names its head of oncology as new research chief

STAT·Nov 20

Pfizer taps oncology head Boshoff as Dolsten’s chief scientific officer successor

Endpoints News·Nov 20

Pfizer Names Chris Boshoff as New Chief Scientific Officer, R&D Chief

Medical Dialogues·Nov 22

View original report at Pfizer ↗

Fetching the latest headlines…